COGT
Cogent Biosciences, Inc.
Stock
$31.02−0.57 (−1.80%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months |
|---|---|
| Revenue | $7.9M |
| Operating income | −$389M |
| Net income | −$377M |
| EPS | −$2.23 |
| Free cash flow | −$309M |
Cogent Biosciences, Inc.
$31.02−0.57 (−1.80%)Close Oct 2, 2026
| Metric | Last 12 months |
|---|---|
| Revenue | $7.9M |
| Operating income | −$389M |
| Net income | −$377M |
| EPS | −$2.23 |
| Free cash flow | −$309M |